FDA Approves ASCOMP WITH CODEINE — LGM PHARMA SOLUTIONS, LLC

LGM Pharma Solutions, LLC (LGM) obtained FDA approval today for ORAL Ascomp with Codeine tablets (generic butalbital, aspirin, caffeine, and codeine phosphate), a combination analgesic containing aspirin. This authorization allows LGM to compete in the generic market with a potentially profitable alternative to branded therapies, driving revenue growth and increasing industry competition.